Skip to main content

Advertisement

SpringerLink
Log in

Prostatic artery embolization must be considered as a valid treatment option of benign prostatic hyperplasia particularly in patients having serious comorbidities

  • Letter to the Editor
  • Published:
World Journal of Urology Aims and scope Submit manuscript

The Original Article was published on 04 December 2022

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability statement

There is no available data related to this article.

References

  1. Raizenne BL, Zheng X, Oumedjbeur K, Mao J, Zorn KC, Elterman D, Bhojani N, McClure T, Te A, Kaplan S, Sedrakyan A, Chughtai B (2023) Prostatic artery embolization compared to transurethral resection of the prostate and prostatic urethral lift: a real-world population-based study. World J Urol 41(1):179–188. https://doi.org/10.1007/s00345-022-04218-6

    Article  PubMed  Google Scholar 

  2. Naidu SG, Narayanan H, Saini G, Segaran N, Alzubaidi SJ, Patel IJ, Oklu R (2021) Prostate artery embolization-review of indications, patient selection, techniques and results. J Clin Med. https://doi.org/10.3390/jcm10215139

    Article  PubMed  PubMed Central  Google Scholar 

  3. Wu X, Zhou A, Heller M, Kohlbrenner R (2022) Prostatic artery embolization versus transurethral resection of the prostate for benign prostatic hyperplasia: a cost-effectiveness analysis. J Vasc Interv Radiol 33(12):1605–1615. https://doi.org/10.1016/j.jvir.2022.08.006

    Article  PubMed  Google Scholar 

Download references

Funding

No grants or funding was provided for this study.

Author information

Authors and Affiliations

  1. Department of Urology, Istanbul University Istanbul School of Medicine, Istanbul, Turkey

    Senol Tonyali

  2. Department of Urology, Faculty of Medicine, University of Freiburg Medical Center, Hugstetter Str. 55, 79106, Freiburg, Germany

    Senol Tonyali & Arkadiusz Miernik

Authors
  1. Senol Tonyali
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arkadiusz Miernik
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

ST, AM: project development, data collection, data analysis, manuscript writing and editing.

Corresponding author

Correspondence to Senol Tonyali.

Ethics declarations

Conflict of interest

The author declares that they have no conflict of interest. Senol Tonyali has received a grant from European Association of Urology Scholarship Programme.

Ethical approval

This article does not contain any studies with human participants performed by the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tonyali, S., Miernik, A. Prostatic artery embolization must be considered as a valid treatment option of benign prostatic hyperplasia particularly in patients having serious comorbidities. World J Urol 41, 1205–1206 (2023). https://doi.org/10.1007/s00345-023-04315-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-023-04315-0

Search

Navigation